ArticleScientific reports2023

Eribulin inhibits growth of cutaneous squamous cell carcinoma cell lines and a novel patient-derived xenograft.

Che-Yuan Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.